Why treat insomnia?

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 1, 2010, Pages

  Matteson Rusby, Sara E ^a   Pigeon, Wilfred R ^a   Gehrman, Philip ^b   Perlis, Michael L ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; ESZOPICLONE; ZALEPLON; ZOLPIDEM;

ARTICLE; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HUMAN; INSOMNIA; JOB PERFORMANCE; JOB SATISFACTION; PREVALENCE; RECURRENT DISEASE; RISK FACTOR; SOCIAL STATUS; TRAFFIC ACCIDENT; TREATMENT INDICATION;

EID: 78650478043     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08r00743bro     Document Type: Article

References (104)

1. Mendelson WB. Long-term follow-up of chronic insomnia. Sleep. 1995;18(8):698-701. PubMed
2. Morin CM, Belanger L, LeBlanc M, et al. The natural history of insomnia: a population-based, 3-year, longitudinal study. Arch Intern Med. 2009;169(5):447-453. PubMed doi:10.1001/archinternmed.2008.610
3. Young TB. Natural history of chronic insomnia. J Clin Sleep Med. 2005;1:e466-e467.
4. Hohagen F, Kappler C, Schramm E, et al. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening: temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep. 1994;17(6):551-554. PubMed
5. LeBlanc M, Mérette C, Savard J, et al. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027-1037. PubMed
6. Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone. 2003;5(3):5-15. PubMed doi:10.1016/S1098-3597(03)90031-7
7. Carey TJ, Moul DE, Pilkonis P, et al. Focusing on the experience of insomnia. Behav Sleep Med. 2005;3(2):73-86. PubMed doi:10.1207/s15402010bsm0302_2
8. Shochat T, Umphress J, Israel AG, et al. Insomnia in primary care patients. Sleep. 1999;22(suppl 2):S359-S365. PubMed
9. American Academy of Sleep Medicine. The International Classification of Sleep Disorders. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
10. Orff HJ, Drummond SPA, Nowakowski S, et al. Discrepancy between subjective symptomatology and objective neuropsychological performance in insomnia. Sleep. 2007;30(9):1205-1211. PubMed
11. Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8):869-893. PubMed doi:10.1016/S0005-7967(01)00061-4
12. Espie CA, Broomfield NM, MacMahon KMA, et al. The attention-intention-effort pathway in the development of psychophysiologic insomnia: an invited theoretical review. Sleep Med Rev. 2006;10(4):215-245. PubMed doi:10.1016/j.smrv.2006.03.002
13. Kuppermann M, Lubeck DP, Mazonson PD. Sleep problems and their correlates in a working population. J Gen Intern Med. 1995;10(1):25-32. PubMed doi:10.1007/BF02599573
14. Johnson L, Spinweber C. Quality of sleep and performance in the navy: a longitudinal study of good and poor sleepers. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evaluation. New York, NY: Raven Press; 1983:13-28.
15. Leger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact of insomnia. Sleep. 2002;25(6):625-629. PubMed
16. Fullerton DS. The economic impact of insomnia in managed care: a clearer picture emerges. Am J Manag Care. 2006;12(suppl 8):S246-S252. PubMed
17. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 1999;22(suppl 2):S386-S393. PubMed
18. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep. 1989;12(6):487-494. PubMed
19. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey II. Sleep. 1999;22(suppl 2):S354-S358. PubMed
20. Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep. 2006;29(3):299-305. PubMed
21. Ozminkowski RJ, Wang SH, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007;30(3):263-273. PubMed
22. NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults: 2005. National Institutes of Health; June 13-15, 2005. http://consensus.nih.gov/2005/2005InsomniaSOS026html.htm.
23. Phillips B, Mannino D. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3(5):489-494. PubMed
24. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45(6):344-350. PubMed doi:10.1539/joh.45.344
25. Schwartz S, McDowell AW, Cole SR, et al. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res. 1999;47(4):313-333. PubMed doi:10.1016/S0022-3999(99)00029-X
26. Mander B, Colecchia E, Spiegel K, et al. Short sleep: a risk factor for insulin resistance and obesity. Diabetes. 2001;50(suppl 2):A45.
27. Knutson KL, Ryden AM, Mander BA, et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006;166(16):1768-1774. doi:10.1001/archinte.166.16.1768 PubMed
28. Kripke DF, Simons RN, Garfinkel L, et al. Short and long sleep and sleeping pills: is increased mortality associated? Arch Gen Psychiatry. 1979;36(1):103-116. PubMed
29. Dew MA, Hoch CC, Buysse DJ, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65(1):63-73. PubMed doi:10.1097/01.PSY.0000039756.23250.7C
30. Pigeon W, Perlis ML. Insomnia and depression: birds of a feather? Int J Sleep Disord. 2007;1:82-91.
31. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262(11):1479-1484. PubMed doi:10.1001/jama.262.11.1479
32. Vollrath M, Wicki W, Angst J. The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci. 1989;239(2):113-124. PubMed doi:10.1007/BF01759584
33. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry. 1991;148(2)174-178. PubMed
34. Dryman A, Eaton WW. Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program. Acta Psychiatr Scand. 1991;84(1):1-5. PubMed doi:10.1111/j.1600-0447.1991.tb01410.x
35. Hohagen F, Rink K, Kappler C, et al. Prevalence and treatment of insomnia in general practice: a longitudinal study. Eur Arch Psychiatry Clin Neurosci. 1993;242(6):329-336. PubMed doi:10.1007/BF02190245
36. Livingston G, Blizard B, Mann A. Does sleep disturbance predict depression in elderly people? a study in inner London. Br J Gen Pract. 1993;43(376):445-448. PubMed
37. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411-418. PubMed doi:10.1016/0006-3223(95)00188-3
38. Weissman MM, Greenwald S, Nino-Murcia G, et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245-250. PubMed doi:10.1016/S0163-8343(97)00056-X
39. Roberts RE, Shema SJ, Kaplan GA, et al. Sleep complaints and depression in an aging cohort: a prospective perspective. Am J Psychiatry. 2000;157(1):81-88. PubMed
40. Livingston G, Watkin V, Milne B, et al. Who becomes depressed? The Islington community study of older people. J Affect Disord. 2000;58(2):125-133. PubMed doi:10.1016/S0165-0327(99)00103-2
41. Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med. 2006;4(2):104-113. PubMed doi:10.1207/s15402010bsm0402_3
42. Paffenbarger RS, Lee IM, Leung R. Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand. 1994;89(suppl 377):16-22. doi:10.1111/j.1600-0447.1994.tb05796.x
43. Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression: The Johns Hopkins Precursors Study. Am J Epidemiol. 1997;146(2):105-114. PubMed
44. Mallon L, Broman JE, Hetta J. Relationship between insomnia, depression, and mortality: a 12-year follow-up of older adults in the community. Int Psychogeriatr. 2000;12(3):295-306. PubMed doi:10.1017/S1041610200006414
45. Perlis ML, Giles DE, Buysse DJ, et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 1997;42(2-3):209-212. doi:10.1016/S0165-0327(96)01411-5 PubMed
46. Pigeon WR, Hegel MT, Unutzer J, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31(4):481-488. PubMed
47. Perlis M, Smith M, Orff H. Commentary on neurobiological basis for the relation between sleep and depression. Sleep Med Rev. 2002;6(5):353-357. PubMed
48. Nowell PD, Mazumdar S, Buysse DJ, et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278(24):2170-2177. PubMed doi:10.1001/jama.278.24.2170
49. Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169. PubMed doi:10.1136/bmj.38623.768588.47
50. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151(8):1172-1180. PubMed
51. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63(1):79-89. PubMed doi:10.1037/0022-006X.63.1.79
52. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11. PubMed doi:10.1176/appi.ajp.159.1.5
53. Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med. 2007;3(1):63-72. PubMed
54. Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev. 2003;7(3):263-279. PubMed doi:10.1053/smrv.2002.0274
55. Leger D, QueraSalva MA, Philip P. Health-related quality of life in patients with insomnia treated with zopiclone. Pharmacoeconomics. 1996;10(suppl 1): 39-44. PubMed doi:10.2165/00019053-199600101-00007
56. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30(8):959-968. PubMed
57. Edinger JD, Wohlgemuth WK, Krystal AD, et al. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med. 2005;165(21):2527-2535. PubMed doi:10.1001/archinte.165.21.2527
58. Pigeon W, Jungquist C, Matteson S, et al. Pain, sleep and mood outcomes in chronic pain patients following cognitive behavioral therapy for insomnia. Sleep. 2007;30:A255-A256.
59. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006 59(11):1052-1060. PubMed doi:10.1016/j.biopsych.2006.01.016
60. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-495. PubMed
61. Taylor DJ, Lichstein KL, Weinstock J, et al. A pilot study of cognitive-behavioral therapy of insomnia in people with mild depression. Behav Ther. 2007;38(1):49-57. PubMed doi:10.1016/j.beth.2006.04.002
62. Lichstein KL. Secondary insomnia: a myth dismissed. Sleep Med Rev. 2006;10:3-5. PubMed doi:10.1016/j.smrv.2005.10.001
63. Lichstein KL, McCrae CS, Wilson NM. Secondary insomnia: Diagnostic issues, cognitive-behavioral treatment and future directions. In: Perlis M, Lichstein KL, eds. Treating Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine. New York, NY: John Wiley & Sons, Inc; 2003:286-304.
64. McCrae CS, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev. 2001;5(1):47-61. PubMed doi:10.1053/smrv.2000.0146
65. McCrae CS, Lichstein KL. Secondary insomnia: a heuristic model and behavioral approaches to assessment, treatment, and prevention. Appl Prev Psychol. 2001;10:107-123.
66. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541-553. PubMed
67. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987;10(1):45-56. PubMed
68. Reynolds CF III, Hoch CC, Buysse DJ, et al. Sleep in late-life recurrent depression: changes during early continuation therapy with nortriptyline. Neuropsychopharmacology. 1991;5(2):85-96. PubMed
69. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225. PubMed
70. Simons AD, Murphy GE, Levine JL, et al. Cognitive therapy and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry. 1986;43(1):43-48. PubMed
71. Thase ME, Simons AD, Cahalane JF, et al. Cognitive behavior therapy of endogenous depression, pt 1: an outpatient clinical replication series. Behav Ther. 1991;22(4):457-467. doi:10.1016/S0005-7894(05)80338-7
72. Manber R, Rush J, Thase ME, et al. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep. 2003;26(2):130-136. PubMed
73. Carney CE, Segal ZV, Edinger JD, et al. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry. 2007;68(2):254-260. PubMed
74. Deviva JC, Zayfert C, Pigeon WR, et al. Treatment of residual insomnia after CBT for PTSD: case studies. J Trauma Stress. 2005;18(2):155-159. PubMed doi:10.1002/jts.20015
75. Germain A, Shear MK, Hall M, et al. Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study. Behav Res Ther. 2007;45(3):627-632. PubMed doi:10.1016/j.brat.2006.04.009
76. Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med. 2006;2(4):403-406. PubMed
77. Jungquist C, O'Brien C, Matteson-Rusby S, et al. The efficacy of cognitive behavioral therapy for insomnia in patients with chronic pain. Sleep Medicine. In press.
78. Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983;14(3):251-256. PubMed doi:10.1016/0005-7916(83)90056-3
79. Currie SR, Wilson KG, Pontefract AJ, et al. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol. 2000;68(3):407-416. PubMed doi:10.1037/0022-006X.68.3.407
80. Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004;99(9):1121-1132. PubMed doi:10.1111/j.1360-0443.2004.00835.x
81. Dashevsky BA, Kramer M. Behavioral treatment of chronic insomnia in psychiatrically ill patients. J Clin Psychiatry. 1998;59(12):693-699. PubMed
82. Davidson JR, Waisberg JL, Brundage MD, et al. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology. 2001;10(5):389-397. PubMed doi:10.1002/pon.525
83. De Berry S. An evaluation of progressive muscle relaxation on stress related symptoms in a geriatric population. Int J Aging Hum Dev. 1981;14(4):255-269. PubMed
84. Dopke CA, Lehner RK, Wells AM. Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluation. Psychiatr Rehabil J. 2004;27(3):235-242. PubMed doi:10.2975/27.2004.235.242
85. French AP, Tupin JP. Therapeutic application of a simple relaxation method. Am J Psychother. 1974;28(2):282-287. PubMed
86. Kolko DJ. Behavioral treatment of excessive daytime sleepiness in an elderly woman with multiple medical problems. J Behav Ther Exp Psychiatry. 1984;15(4):341-345. PubMed doi:10.1016/0005-7916(84)90099-5
87. Krakow B, Hollifield M, Johnston L, et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001;286(5):537-545. PubMed doi:10.1001/jama.286.5.537
88. Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging. 2000;15(2):232-240. PubMed doi:10.1037/0882-7974.15.2.232
89. Morawetz D. Depression and insomnia. Aust Fam Physician. 2000;29(11):1016. PubMed
90. Morin CM, Kowatch RA, Wade JB. Behavioral management of sleep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatry. 1989;20(4):295-302. PubMed doi:10.1016/0005-7916(89)90060-8
91. Quesnel C, Savard J, Simard S, et al. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol. 2003;71(1):189-200. PubMed doi:10.1037/0022-006X.71.1.189
92. Savard J, Simard S, Ivers H, et al. A randomized study of on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, pt 1: sleep and psychological effects. J Clin Oncol. 2005;23(25):6083-6096. PubMed doi:10.1200/JCO.2005.09.548
93. Rybarczyk B, Lopez M, Benson R, et al. Efficacy of two behavioral treatment programs for comorbid geriatric insomnia. Psychol Aging. 2002;17(2):288-298. PubMed doi:10.1037/0882-7974.17.2.288
94. Perlis ML, Sharpe M, Smith MT, et al. Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidity. J Behav Med. 2001;24(3):281-296. PubMed doi:10.1023/A:1010770807823
95. Stam HJ, Bultz BD. The treatment of severe insomnia in a cancer patient. J Behav Ther Exp Psychiatry. 1986;17(1):33-37. PubMed doi:10.1016/0005-7916(86)90008-X
96. Tan TL, Kales JD, Kales A, et al. Inpatient multidimensional management of treatment-resistant insomnia. Psychosomatics. 1987;28(5):266-272. PubMed
97. Schaefer K, McCall W, Krystal A, et al. Relative effect sizes of eszopiclone treatment for insomnia in patients with primary insomnia and insomnia comorbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis. Sleep. 2007;30:A243-A244.
98. Varni JW. Behavioral treatment of disease-related chronic insomnia in a hemophiliac. J Behav Ther Exp Psychiatry. 1980;11(2):143-145. doi:10.1016/0005-7916(80)90013-0
99. Perlis M, Gehrman P, Riemann D. Intermittent and long-term use of sedative hypnotics. Curr Pharm Des. 2008;14(32):3456-3465. PubMed doi:10.2174/138161208786549290
100. Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3):205-214. PubMed doi:10.1016/j.smrv.2008.06.001
101. Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al. Cancer-related fatigue and sleep disorders. Oncologist. 2007;12(suppl 1):35-42. PubMed doi:10.1634/theoncologist.12-S1-35
102. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep. 1999;22(suppl 2):S354-S358.PubMed
103. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. 1999;22(suppl 2):S379-S385. PubMed
104. Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16(5):873-897. PubMed